A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial
A Study to Evaluate the Safety, Tolerability, and Efficacy of IMB-1018972 in Patients With Non-obstructive Hypertrophic Cardiomyopathy Trial
The purpose of this study is to assess the safety, tolerability, and potential efficacy of
 IMB-1018972 in patients with non-obstructive HCM.
Inclusion Criteria:

 -  Diagnosis of Hypertrophic Cardiomyopathy consistent with current US and European
 guidelines

 -  Ability to perform an upright treadmill cardiopulmonary exercise test

 -  Agreement to abide by contraceptive requirements

 Exclusion Criteria:

 -  Clinically significant concurrent condition which could prevent the patient from
 performing any of the protocol-specified assessments, represent a safety concern if
 the patient participates in the trial or could confound trial assessments of safety or
 tolerability

 -  Women who are pregnant, planning to become pregnant or lactating

 -  Participation in another clinical study involving a test product or invasive medical
 device within 28 days (or within 5 elimination half-lives of the respective test
 product, whichever is longer), prior to first dosing